Response to letter to the editor: “Assay-specific spurious ACTH results lead to misdiagnosis, unnecessary testing, and surgical misadventure—a case series”

Loren Wissner Greene; Eliza B. Geer; Gabrielle Page-Wilson; James W. Findling; Hershel Raff

doi:10.1210/jendso/bvz012

Response to letter to the editor: “Assay-specific spurious ACTH results lead to misdiagnosis, unnecessary testing, and surgical misadventure—a case series”

Loren Wissner Greene
, Eliza B. Geer
, Gabrielle Page-Wilson
, James W. Findling
, Hershel Raff

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Journal	Journal of the Endocrine Society
Volume	4
Issue number	2
DOIs	https://doi.org/10.1210/jendso/bvz012
State	Published - 1 Feb 2020
Externally published	Yes

Access to Document

10.1210/jendso/bvz012

Cite this

@article{a6f2da4cbf5440849334379fd22b1bfb,

title = "Response to letter to the editor: “Assay-specific spurious ACTH results lead to misdiagnosis, unnecessary testing, and surgical misadventure—a case series”",

author = "Greene, \{Loren Wissner\} and Geer, \{Eliza B.\} and Gabrielle Page-Wilson and Findling, \{James W.\} and Hershel Raff",

note = "Funding Information: Disclosure Summary: EBG has received consulting fees from Strongbridge, Corcept, Pfizer, and grants from Novartis Pharmaceuticals, Ionis Pharmaceuticals Inc., Strongbridge, and Chiasma. GP-W has received consulting fees from Strongbridge. JWF has received consulting fees from Corcept Therapeutics and Novartis Pharmaceuticals and has been a research investigator for Corcept Therapeutics and Novartis Pharmaceuticals. HR has received consulting fees and reagents from Corcept Therapeutics and consulting fees and a research grant from Cerium Pharmaceuticals. The remaining author has nothing to disclose.",

year = "2020",

month = feb,

day = "1",

doi = "10.1210/jendso/bvz012",

language = "English",

volume = "4",

journal = "Journal of the Endocrine Society",

issn = "2472-1972",

publisher = "Endocrine Society",

number = "2",

}

TY - JOUR

T1 - Response to letter to the editor

T2 - “Assay-specific spurious ACTH results lead to misdiagnosis, unnecessary testing, and surgical misadventure—a case series”

AU - Greene, Loren Wissner

AU - Geer, Eliza B.

AU - Page-Wilson, Gabrielle

AU - Findling, James W.

AU - Raff, Hershel

N1 - Funding Information: Disclosure Summary: EBG has received consulting fees from Strongbridge, Corcept, Pfizer, and grants from Novartis Pharmaceuticals, Ionis Pharmaceuticals Inc., Strongbridge, and Chiasma. GP-W has received consulting fees from Strongbridge. JWF has received consulting fees from Corcept Therapeutics and Novartis Pharmaceuticals and has been a research investigator for Corcept Therapeutics and Novartis Pharmaceuticals. HR has received consulting fees and reagents from Corcept Therapeutics and consulting fees and a research grant from Cerium Pharmaceuticals. The remaining author has nothing to disclose.

PY - 2020/2/1

Y1 - 2020/2/1

UR - https://www.scopus.com/pages/publications/85083052978

U2 - 10.1210/jendso/bvz012

DO - 10.1210/jendso/bvz012

M3 - Letter

AN - SCOPUS:85083052978

SN - 2472-1972

VL - 4

JO - Journal of the Endocrine Society

JF - Journal of the Endocrine Society

IS - 2

ER -